Approval · Notice of Compliance 9514 · 2008
IDAMYCIN: Notice of Compliance 9514
Issued April 23, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9514
- Date
- April 23, 2008
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph: removal of references to oral formulation
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IDAMYCIN | Not yet assigned | — |
| IDAMYCIN PFS | Not yet assigned | — |
Medicinal ingredients
- IDARUBICIN HCL 5 MG per VIAL
- IDARUBICIN HCL 10 MG per VIAL
- IDARUBICIN HCL 1 MG per ML